Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease

American Association for the Advancement of Science (AAAS) - Tập 352 Số 6289 - Trang 1116-1120 - 2016
Hiutung Chu1, Arya Khosravi1, Indah P. Kusumawardhani1, Alice H. K. Kwon1, A.C. Vasconcelos2, Larissa D. Cunha3, A. Mayer4, Yue Shen1, Wei‐Li Wu1, Amal Kambal4, Stephan R. Targan5, Ramnik J. Xavier6, Peter B. Ernst2, Douglas R. Green3, Dermot McGovern5, Herbert W. Virgin4, Sarkis K. Mazmanian1
1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA
2Center for Veterinary Sciences and Comparative Medicine, University of California, San Diego, San Diego, CA 92093, USA.
3Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA
4Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA
5F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
6Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA

Tóm tắt

Genes and microbes converge in colitis Both host genetics and intestinal microbes probably contribute to a person's overall susceptibility to inflammatory bowel disease (IBD). The human gut microbe Bacteroides fragilis produces immunomodulatory molecules that it releases via outer membrane vesicles (OMVs). These molecules can protect mice from experimentally induced colitis. Chu et al. now find that OMV-mediated protection from colitis requires Atg16l1 and Nod2 genes whose human orthologs are associated with an increased risk for developing IBD. OMVs trigger an ATG16L1 and NOD2–dependent noncanonical autophagy pathway in dendritic cells (DCs). OMV-primed DCs, in turn, induce regulatory T cells in the intestine that protect against colitis. Science , this issue p. 1116

Từ khóa


Tài liệu tham khảo

10.1016/j.chom.2008.05.001

10.1146/annurev-immunol-030409-101330

10.1146/annurev-immunol-020711-074937

10.1038/ni.2611

10.1016/j.cell.2014.03.011

10.1126/science.1223490

10.1002/ibd.21385

10.1080/003655200451207

10.1016/S0016-5085(03)00385-8

10.1136/gut.29.7.990

10.1038/nature11582

10.1016/j.chom.2015.04.008

10.1038/ng1954

10.1038/ng2032

10.1038/ng2061

10.1016/j.coi.2012.08.001

10.1038/35079107

10.1038/35079114

10.1126/science.1104911

10.1038/ni.1823

10.1038/nm.2069

10.1038/nature13044

10.1073/pnas.1407001111

10.1038/nature07383

10.1016/j.cell.2010.05.009

10.1016/j.immuni.2014.09.011

10.1016/j.chom.2015.12.010

10.1016/j.chom.2015.12.011

10.1038/nature16451

10.1038/nature07008

10.1073/pnas.0909122107

10.1111/j.1600-065X.2008.00634.x

10.1016/j.chom.2012.08.004

10.1038/ni.3365

10.7554/eLife.12444

10.1038/ncb3192

10.1126/science.1206095

10.1038/nature06421

10.1038/nature05911

10.1097/QCO.0b013e32832a8a5d

10.1053/j.gastro.2011.10.001

10.1016/j.chom.2012.03.002

10.1038/ncb1846

10.1182/blood-2008-02-137398

10.1128/IAI.69.7.4342-4350.2001

10.1099/00222615-16-2-239

10.1152/ajpgi.00404.2013